ACE and Hyperkalemia: This is important as hyperkalemia may be a harbinger for adverse outcomes, can lead to discontinuation of medications with proven benefit such as angiotensin converting enzyme (ACE) inhibitors or angiotensinogen receptor blockers (ARB) and contributes to increased health care resources and cost.2,4,19,20